PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)

IDX:DGNS Cash Flow Statement

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	747.44	-13,656	12,665	64,304	52,687
Depreciation & Amortization	14,883	14,634	13,310	7,562	3,842
Other Operating Activities	11,668	12,205	-31,931	-12,990	-30,300
Operating Cash Flow	27,299	13,184	-5,956	58,875	26,228
Operating Cash Flow Growth	107.07%	-	-	124.47%	134.26%
Capital Expenditures	-43,394	-38,324	-34,096	-67,841	-5,864
Sale of Property, Plant & Equipment	117.12	649.65	-	-	-
Sale (Purchase) of Intangibles	-904.18	-208	-756.8	-	-
Investment in Securities	-	-4,506	-8,051	-6,507	-
Other Investing Activities	-	-	25,354	-1,219	28,138
Investing Cash Flow	-44,181	-42,389	-17,550	-75,568	22,274
Long-Term Debt Issued	15,000	38,978	11,606	-	-
Long-Term Debt Repaid	-2,744	-23,728	-4,749	-4,900	-2,933
Net Debt Issued (Repaid)	12,256	15,250	6,857	-4,900	-2,933
Issuance of Common Stock	-	-	-	49,478	-
Common Dividends Paid	-	-	-	-6,000	-
Other Financing Activities	-1,409	-3,810	-	6,296	-30,424
Financing Cash Flow	10,846	11,439	6,857	44,874	-33,358
Miscellaneous Cash Flow Adjustments	-	-	-60	-	-
Net Cash Flow	-6,036	-17,766	-16,709	28,182	15,145
Free Cash Flow	-16,095	-25,141	-40,052	-8,966	20,365
Free Cash Flow Growth	-	-	-	-	142.03%
Free Cash Flow Margin	-9.87%	-17.26%	-20.77%	-2.97%	11.12%
Free Cash Flow Per Share	-12.88	-20.11	-32.04	-7.23	20.36
Cash Interest Paid	2,614	475.24	772	-	-
Cash Income Tax Paid	-	10.08	20,082	16,185	6,955
Levered Free Cash Flow	-20,631	-17,955	-13,691	-29,353	-17,491
Unlevered Free Cash Flow	-20,080	-17,658	-13,298	-29,146	-17,491
Change in Net Working Capital	-8,133	-15,710	2,442	19,760	57,335

Source: S&P Global Market Intelligence. Standard template. Financial Sources.